Mairin Joseph Talreja, MD
Gastroenterology · Houston
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Ut Physicians · 1,744 clinicians in this group
Hospitals listed: Memorial Hermann Texas Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Talreja’s office at (713) 704-3450 to ask if they take your plan before you enroll.
California Medical Board record
Licence A142295 · Current
Licensed to practise in California · since 2016 · expires 2027-10-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas T2190Physician License · since 2021 · expires 2028-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Hermann - Texas Medical CenterHouston, TXAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Memorial Hermann Healthcare System, which runs 11 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.51 (4.11 to 6.91) · 3,925 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.233, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorial Hermann - Texas Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.51 (4.11 to 6.91) · 3,925 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.233 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.15 to 1.85) · 2,066 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.84 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.49 (130.91 to 186.06) · 360 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 12.3 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 150 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 418 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.3 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 976 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,309 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 9,923 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.35) · 9,628 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.07 (0 to 2.46) · 996 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.88 (1.75 to 4.02) · 3,572 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.9 (1.25 to 10.54) · 1,048 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.07 (5.09 to 11.06) · 1,039 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.33 to 3.09) · 612 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.24 to 0.97) · 9,104 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.875 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.358 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.255 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 414 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 1,092 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.5 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6 · 517 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (2.8 to 6.3) · 128 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.7) · 128 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 211 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (8.9 to 15.2) · 1,039 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 645 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,509 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$20,179
Medicare paid this office $20,179 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,948 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,917 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $607 | $40 |
Procedures Medicare counted
| Colonoscopy | 18 | More than 46% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 123 | More than 81% of doctors who do this |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 72 · Women 57% · Also on Medicaid 23% · Health risk score 2.36. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 44% · Heart failure 38% · Chronic kidney disease 37% · Atrial fibrillation 28% · COPD 27% · Depression 24% · Dementia 15% · Cancer 14% · Stroke 14%.
The office billed $173,202, Medicare allowed $26,480 and paid $20,179; for 212 services of 53 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 79 | 212 | 72 | 2.36 | $173,202 | $20,179 |
| 2023 | 132 | 269 | 70 | 2.29 | $225,227 | $32,141 |
| 2022 | 52 | 109 | 69 | 3.12 | $74,092 | $10,359 |
| 2021 | 22 | 34 | 74 | 2.03 | $14,206 | $2,553 |
| 2017 | 35 | 36 | 57 | 5.76 | $17,556 | $4,916 |
| 2016 | 12 | 12 | 65 | 2.48 | $4,623 | $1,316 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,673 | $107 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,144 | $179 |
| New patient visit (45+ min) | 21 | $2,084 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,845 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,364 | $65 |
| Short return visit (20+ min) | 13 | $852 | $57 |
| New patient visit (30+ min) | 12 | $824 | $69 |
2022: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $922 | $54 |
2017: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,441 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,994 | $181 |
Drugs they prescribed that Part D paid
$35,299
Pharmacies billed $35,299 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
162 generic and 50 brand-name prescriptions · $35,299 in drug cost · 16 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 27 | $17,244 | $639 |
| Esomeprazole Magnesium | 21 | $954 | $45 |
| Sod Sulf-Potass Sulf-Mag Sulf | 12 | $769 | $64 |
| Omeprazole | 48 | $565 | $12 |
| Sucralfate | 13 | $459 | $35 |
See all 7 drugs
| Linzess | 27 | $17,244 | $639 |
| Esomeprazole Magnesium | 21 | $954 | $45 |
| Sod Sulf-Potass Sulf-Mag Sulf | 12 | $769 | $64 |
| Omeprazole | 48 | $565 | $12 |
| Sucralfate | 13 | $459 | $35 |
| Gavilyte-G | 15 | $217 | $14 |
| Pantoprazole | 22 | $111 | $5 |
Year by year
| 2024 | 212 | 80 | None | 24% | $35,299 |
| 2023 | 220 | 107 | None | 20% | $33,091 |
| 2022 | 56 | 37 | None | None | $6,723 |
| 2021 | 42 | 27 | None | None | $922 |
| 2020 | 57 | 28 | 0% (0) | None | $5,222 |
| 2019 | 16 | None | 0% (0) | 0% | $504 |
| 2018 | 58 | 32 | None | None | $2,985 |
| 2017 | 67 | 36 | None | None | $1,443 |
| 2016 | 264 | 29 | None | None | $7,669 |
| 2015 | 207 | 28 | None | None | $9,234 |
| 2014 | 82 | 18 | None | 27% | $9,362 |
| 2013 | 120 | 34 | None | None | $13,356 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Linzess | 13 | $9,094 | $700 |
| Omeprazole | 40 | $1,048 | $26 |
| Gavilyte-G | 48 | $717 | $15 |
| Sucralfate | 16 | $562 | $35 |
| Pantoprazole | 20 | $198 | $10 |
2022: 1 drug
| Omeprazole | 11 | $197 | $18 |
2021: 1 drug
| Omeprazole | 20 | $276 | $14 |
2020: 1 drug
| Pantoprazole | 15 | $119 | $8 |
2016: 6 drugs
| Atorvastatin | 28 | $251 | $9 |
| Constulose | 12 | $173 | $14 |
| Amlodipine Besylate | 14 | $100 | $7 |
| Lisinopril | 15 | $89 | $6 |
| Metoprolol | 11 | $56 | $5 |
| Furosemide | 12 | $22 | $2 |
2015: 3 drugs
| Pravastatin | 13 | $360 | $28 |
| Lactulose | 24 | $172 | $7 |
| Hydrochlorothiazide | 12 | $76 | $6 |
Money from drug and device companies
$257 in 2025
| 2025 | 3 | 5 | None | $257 |
| 2024 | 6 | 13 | None | $1,016 |
| 2023 | 9 | 20 | None | $1,817 |
| 2022 | 3 | 16 | None | $1,273 |
| 2021 | 1 | 2 | None | $176 |
| 2020 | 2 | 2 | None | $40 |
| 2019 | 2 | 4 | None | $322 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Overstitch Endoscopic Suturing System | $132 | 3 payments
|
| Conmed | Conmed Generators | $96 | 1 payment
|
| Ambu | None | $29 | 1 payment
|
See all 5 published payments
| Ambu | Meals · 2025-08-21 | None | $29 |
| Boston Scientific | Meals · 2025-07-16 | Wallflex Duodenal | $16 |
| Boston Scientific | Meals · 2025-03-19 | Overstitch Endoscopic Suturing System | $98 |
| Boston Scientific | Meals · 2025-03-19 | Overstitch Endoscopic Suturing System | $18 |
| Conmed | Meals · 2025-01-29 | Conmed Generators | $96 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,016
| Conmed | Conmed Biliary | $496 | 7 payments
|
| 3-D Matrix | None | $174 | 1 payment
|
| Steris | None | $135 | 1 payment
|
| Boston Scientific | Exalt Model D | $121 | 2 payments
|
| Medtronic | Barrx | $59 | 1 payment
|
| Abbvie | Creon | $31 | 1 payment
|
2023: $1,817
| Boston Scientific | Wallflex Duodenal | $641 | 9 payments
|
| Conmed | Conmed Generators | $317 | 3 payments
|
| Olympus America | Evis Exera III Video System Center | $183 | 2 payments
|
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $146 | 1 payment
|
| Medtronic | Nexpowder | $136 | 1 payment
|
| Ethicon US | Linx Reflux Management System | $125 | 1 payment
|
| PENTAX of America | Inspira | $118 | 1 payment
|
| Abbvie | Creon | $93 | 1 payment
|
| FUJIFILM Healthcare Americas | Fujifilm | $59 | 1 payment
|
2022: $1,273
| Boston Scientific | General - Therapies | $756 | 12 payments
|
| Abbvie | Creon | $291 | 2 payments
|
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $227 | 2 payments
|
2021: $176
| Boston Scientific | General Therapies | $176 | 2 payments
|
2020: $40
| AbbVie | Humira | $24 | 1 payment
|
| PENTAX of America | Capsovision | $16 | 1 payment
|
2019: $322
| Olympus Corporation of the Americas | Evis Exera | $179 | 3 payments
|
| Dova Pharmaceuticals | Doptelet | $143 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619239308
- Licence
- CA A142295, MA 252764, RI LP03249, TX T2190California A142295: Current · expires 2027-10-31Texas T2190: Active
- Group
- Ut Physicians
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 6431 Fannin St # 4.234, Houston, TX, 77030
- NPI first listed
- 2012-06-09
- NPI last updated
- 2021-07-08
- NPI record certified
- 2021-07-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Clarkson Ave # Msc1196, Brooklyn, NY, 11203 · 300 Pasteur Dr, Stanford, CA, 94305